XBiotech Inc.
XBIT
$2.20
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.28M | 7.43M | 8.30M | 4.83M | 4.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 48.22M | 48.41M | 55.69M | 34.68M | 36.54M |
| Operating Income | -48.22M | -48.41M | -55.69M | -34.68M | -36.54M |
| Income Before Tax | -44.86M | -39.91M | -45.31M | -29.04M | -28.14M |
| Income Tax Expenses | 273.00K | 255.00K | 235.00K | 118.00K | 25.00K |
| Earnings from Continuing Operations | -45.13 | -40.16 | -45.54 | -29.16 | -28.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -45.13M | -40.16M | -45.54M | -29.16M | -28.16M |
| EBIT | -48.22M | -48.41M | -55.69M | -34.68M | -36.54M |
| EBITDA | -46.78M | -46.84M | -54.00M | -32.93M | -34.78M |
| EPS Basic | -1.48 | -1.32 | -1.49 | -0.96 | -0.92 |
| Normalized Basic EPS | -0.93 | -0.83 | -0.94 | -0.60 | -0.58 |
| EPS Diluted | -1.48 | -1.32 | -1.49 | -0.96 | -0.92 |
| Normalized Diluted EPS | -0.93 | -0.83 | -0.94 | -0.60 | -0.58 |
| Average Basic Shares Outstanding | 121.95M | 121.95M | 121.95M | 121.93M | 121.91M |
| Average Diluted Shares Outstanding | 121.95M | 121.95M | 121.95M | 121.93M | 121.91M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |